Table 3.
Results from dose plan analysis for Patient 2
| Obj. | HT | IMP | RA | |
| PTVII | ||||
| Mean [Gy] | 49.5 | 49.5 (100%) |
49.5 (100%) |
49.5 (100%) |
| D1% [%] | - | 103.2 | 103.8 | 103.4 |
| D99% [%] | - | 93.3 | 94.7 | 92.7 |
| V90% [%] | 100% | 99.9 | 100.0 | 99.8 |
| V95% [%] | 100% | 97.5 | 98.7 | 96.2 |
| V107% [%] | 0% | 0.0 | 0.0 | 0.0 |
| V110% [%] | 0% | 0.0 | 0.0 | 0.0 |
| D5–D95 [%] | - | 6.5 | 5.9 | 7.3 |
| SD [%] | - | 1.8 | 1.8 | 2.2 |
| CI90 | 1.0 | 1.1 | 1.1 | 1.0 |
| PTVI-PTVII | ||||
| Mean [%] | 45.0 | 47.0 (104.4%) |
47.6 (105.8%) |
46.7 (103.8%) |
| D1% [%] | - | 112.9 | 113.1 | 111.3 |
| D99% [%] | - | 92.9 | 95.3 | 91.1 |
| V90% [%] | 100% | 99.7 | 99.9 | 99.3 |
| V95% [%] | 100% | 98.1 | 99.2 | 95.4 |
| V107% [%] | 0% | 31.2 | 45.6 | 28.3 |
| V110% [%] | 0% | 11.6 | 6.7 | 6.3 |
| D5–D95 [%] | - | 13.8 | 11.6 | 15.1 |
| SD [%] | - | 4.4 | 3.6 | 4.7 |
| Vertebra | ||||
| Mean [Gy] | < 20 Gy | 10.5 | 4.3 | 10.5 |
| D1% [Gy] | < 45 Gy | 25.8 | 37.2 | 34.8 |
| Spinal Cord | ||||
| D1% [Gy] | < 45 Gy | 11.0 | 1.4 | 10.1 |
| Right Lung | ||||
| Mean [Gy] | < 15 Gy | 9.1 | 3.6 | 7.7 |
| V5 Gy [%] | Minim | 47.7 | 16.5 | 43.7 |
| V20 Gy [%] | Minim | 14.8 | 6.9 | 13.6 |
| Left Lung | ||||
| Mean [Gy] | < 15 Gy | 13.2 | 7.0 | 12.0 |
| V5 Gy [%] | Minim | 63.7 | 30.9 | 54.0 |
| V20 Gy [%] | Minim | 27.0 | 14.0 | 26.4 |
| Heart | ||||
| Mean [Gy] | < 30 Gy | 6.5 | 2.4 | 2.3 |
| V20 Gy [%] | Minim | 13.2 | 5.0 | 2.7 |
| D1% [Gy] | Minim | 42.1 | 38.0 | 31.1 |
| Healthy tissue | ||||
| Mean Gy] | Minim | 5.0 | 1.7 | 4.0 |
| V10 Gy [cm3] | Minim | 18.9 | 5.4 | 8.9 |
| EI [%] | Minim | 0.0 | 0.1 | 0.0 |
| DosInt [105 *Gy*cm3] | Minim | 0.29 | 0.10 | 0.23 |